Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2002 Jan;78(915):27–30. doi: 10.1136/pmj.78.915.27

Acute myocardial infarction in young adults: causes and management

S Osula 1, G Bell 1, R Hornung 1
PMCID: PMC1742222  PMID: 11796868

Abstract

The case report in this review illustrates an acute myocardial infarction in a young adult probably due to arterial thrombosis that can be attributed to a hypercoagulable state resulting from the nephrotic syndrome. Although rare, acute myocardial infarction should be considered in young adults presenting with chest pain. A detailed clinical history may help to identify the aetiology, and guide subsequent management, but diagnostic coronary angiography is essential. Careful risk factor modification and treatment of the underlying cause should reduce the incidence of recurrent cardiac events.

Full Text

The Full Text of this article is available as a PDF (72.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agirbasli M. A., Hansen D. E., Byrd B. F., 3rd Resolution of vegetations with anticoagulation after myocardial infarction in primary antiphospholipid syndrome. J Am Soc Echocardiogr. 1997 Oct;10(8):877–880. doi: 10.1016/s0894-7317(97)70050-6. [DOI] [PubMed] [Google Scholar]
  2. Andrassy K., Ritz E., Bommer J. Hypercoagulability in the Nephrotic syndrome. Klin Wochenschr. 1980 Oct 1;58(19):1029–1036. doi: 10.1007/BF01476873. [DOI] [PubMed] [Google Scholar]
  3. Booth G. L., Wang E. E. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care. CMAJ. 2000 Jul 11;163(1):21–29. [PMC free article] [PubMed] [Google Scholar]
  4. Carvalho A. C., Colman R. W., Lees R. S. Platelet function in hyperlipoproteinemia. N Engl J Med. 1974 Feb 21;290(8):434–438. doi: 10.1056/NEJM197402212900805. [DOI] [PubMed] [Google Scholar]
  5. Castro V. J., Nacht R. Cocaine-induced bradyarrhythmia: an unsuspected cause of syncope. Chest. 2000 Jan;117(1):275–277. doi: 10.1378/chest.117.1.275. [DOI] [PubMed] [Google Scholar]
  6. Connolly D. L., Dardas P. S., Crowley J. J., Kenny A., Petch M. C. Acute coronary embolism complicating aortic valve endocarditis treated with streptokinase and aspirin. A case report. J Heart Valve Dis. 1994 May;3(3):245–246. [PubMed] [Google Scholar]
  7. Cuadrado M. J., Mujic F., Muñoz E., Khamashta M. A., Hughes G. R. Thrombocytopenia in the antiphospholipid syndrome. Ann Rheum Dis. 1997 Mar;56(3):194–196. doi: 10.1136/ard.56.3.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dagalp Z., Pamir G., Alpman A., Omurlu K., Erol C., Oral D. Coronary artery aneurysms. Report of two cases and review of the literature. Angiology. 1996 Feb;47(2):197–201. doi: 10.1177/000331979604700212. [DOI] [PubMed] [Google Scholar]
  9. Dressler F. A., Malekzadeh S., Roberts W. C. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am J Cardiol. 1990 Feb 1;65(5):303–308. doi: 10.1016/0002-9149(90)90292-9. [DOI] [PubMed] [Google Scholar]
  10. Espínola-Zavaleta N., Vargas-Barrón J., Colmenares-Galvis T., Cruz-Cruz F., Romero-Cárdenas A., Keirns C., Amigo M. C. Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Am Heart J. 1999 May;137(5):973–978. doi: 10.1016/s0002-8703(99)70424-2. [DOI] [PubMed] [Google Scholar]
  11. Evans SM, Brittenden J, Adam DJ, Ludlam C, Bradbury AW. Vascular surgical society of great britain and ireland: prevalence and significance of thrombophilia in patients with intermittent claudication . Br J Surg. 1999 May;86(5):702–703. doi: 10.1046/j.1365-2168.1999.0702b.x. [DOI] [PubMed] [Google Scholar]
  12. Fahal I. H., McClelland P., Hay C. R., Bell G. M. Arterial thrombosis in the nephrotic syndrome. Postgrad Med J. 1994 Dec;70(830):905–909. doi: 10.1136/pgmj.70.830.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Flores E. D., Lange R. A., Cigarroa R. G., Hillis L. D. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses. J Am Coll Cardiol. 1990 Jul;16(1):74–79. doi: 10.1016/0735-1097(90)90459-3. [DOI] [PubMed] [Google Scholar]
  14. Fujimura O., Gulamhusein S. Acute myocardial infarction: thrombotic complications of nephrotic syndrome. Can J Cardiol. 1987 Sep;3(6):267–269. [PubMed] [Google Scholar]
  15. Gaeta G., De Michele M., Cuomo S., Guarini P., Foglia M. C., Bond M. G., Trevisan M. Arterial abnormalities in the offspring of patients with premature myocardial infarction. N Engl J Med. 2000 Sep 21;343(12):840–846. doi: 10.1056/NEJM200009213431203. [DOI] [PubMed] [Google Scholar]
  16. Hamamichi Y., Okada E., Ichida F. Anomalous origin of the main stem of the left coronary artery from the non-facing sinus of valsalva associated with sudden death in a young athlete. Cardiol Young. 2000 Mar;10(2):147–149. doi: 10.1017/s1047951100006624. [DOI] [PubMed] [Google Scholar]
  17. Hamsten A., Norberg R., Björkholm M., de Faire U., Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet. 1986 Jan 18;1(8473):113–116. doi: 10.1016/s0140-6736(86)92258-0. [DOI] [PubMed] [Google Scholar]
  18. Harats D., George J., Levy Y., Khamashta M. A., Hughes G. R., Shoenfeld Y. Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus. QJM. 1999 Jan;92(1):57–59. doi: 10.1093/qjmed/92.1.57. [DOI] [PubMed] [Google Scholar]
  19. Ho Y. L., Chen M. F., Wu C. C., Chen W. J., Lee Y. T. Successful treatment of acute myocardial infarction by thrombolytic therapy in a patient with primary antiphospholipid antibody syndrome. Cardiology. 1996 Jul-Aug;87(4):354–357. doi: 10.1159/000177119. [DOI] [PubMed] [Google Scholar]
  20. Holmes D. R., Jr, White H. D., Pieper K. S., Ellis S. G., Califf R. M., Topol E. J. Effect of age on outcome with primary angioplasty versus thrombolysis. J Am Coll Cardiol. 1999 Feb;33(2):412–419. doi: 10.1016/s0735-1097(98)00579-8. [DOI] [PubMed] [Google Scholar]
  21. Horejsí B., Ceska R. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis. Physiol Res. 2000;49 (Suppl 1):S63–S69. [PubMed] [Google Scholar]
  22. Huang C. N., Wu D. J., Chen K. S. Acute myocardial infarction caused by transnasal inhalation of amphetamine. Jpn Heart J. 1993 Nov;34(6):815–818. doi: 10.1536/ihj.34.815. [DOI] [PubMed] [Google Scholar]
  23. Hughes G. R. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) 1983 Oct 15;287(6399):1088–1089. doi: 10.1136/bmj.287.6399.1088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jouhikainen T., Pohjola-Sintonen S., Stephansson E. Lupus anticoagulant and cardiac manifestations in systemic lupus erythematosus. Lupus. 1994 Jun;3(3):167–172. doi: 10.1177/096120339400300307. [DOI] [PubMed] [Google Scholar]
  25. Kendall A. G., Lohmann R. C., Dossetor J. B. Nephrotic syndrome. A hypercoagulable state. Arch Intern Med. 1971 Jun;127(6):1021–1027. [PubMed] [Google Scholar]
  26. Khamashta M. A., Cervera R., Asherson R. A., Font J., Gil A., Coltart D. J., Vázquez J. J., Paré C., Ingelmo M., Oliver J. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet. 1990 Jun 30;335(8705):1541–1544. doi: 10.1016/0140-6736(90)91373-i. [DOI] [PubMed] [Google Scholar]
  27. Klues H. G., Schwarz E. R., vom Dahl J., Reffelmann T., Reul H., Potthast K., Schmitz C., Minartz J., Krebs W., Hanrath P. Disturbed intracoronary hemodynamics in myocardial bridging: early normalization by intracoronary stent placement. Circulation. 1997 Nov 4;96(9):2905–2913. doi: 10.1161/01.cir.96.9.2905. [DOI] [PubMed] [Google Scholar]
  28. Lee B. W., Tay J. S., Yip W. C., Yap H. K., Chan K. Y., Low P. S. Kawasaki syndrome in Chinese children. Ann Trop Paediatr. 1989 Sep;9(3):147–151. doi: 10.1080/02724936.1989.11748618. [DOI] [PubMed] [Google Scholar]
  29. Manzar K. J., Padder F. A., Conrad A. R., Freeman I., Jonas E. A. Acute myocardial infarction with normal coronary artery: a case report and review of literature. Am J Med Sci. 1997 Nov;314(5):342–345. doi: 10.1097/00000441-199711000-00013. [DOI] [PubMed] [Google Scholar]
  30. Mathew J., Addai T., Anand A., Morrobel A., Maheshwari P., Freels S. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med. 1995 Aug 7;155(15):1641–1648. [PubMed] [Google Scholar]
  31. Moreyra A. E., Kostis J. B., Passannante A. J., Kuo P. T. Acute myocardial infarction in patients with normal coronary arteries after acute ethanol intoxication. Clin Cardiol. 1982 Jul;5(7):425–430. doi: 10.1002/clc.4960050707. [DOI] [PubMed] [Google Scholar]
  32. Penny W. J., Colvin B. T., Brooks N. Myocardial infarction with normal coronary arteries and factor XII deficiency. Br Heart J. 1985 Feb;53(2):230–234. doi: 10.1136/hrt.53.2.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pitts W. R., Lange R. A., Cigarroa J. E., Hillis L. D. Cocaine-induced myocardial ischemia and infarction: pathophysiology, recognition, and management. Prog Cardiovasc Dis. 1997 Jul-Aug;40(1):65–76. doi: 10.1016/s0033-0620(97)80023-0. [DOI] [PubMed] [Google Scholar]
  34. Remuzzi G., Mecca G., Marchesi D., Livio M., de Gaetano G., Donati M. B., Silver M. J. Platelet hyperaggregability and the nephrotic syndrome. Thromb Res. 1979;16(3-4):345–354. doi: 10.1016/0049-3848(79)90082-3. [DOI] [PubMed] [Google Scholar]
  35. Reverter J. C., Tàssies D., Font J., Khamashta M. A., Ichikawa K., Cervera R., Escolar G., Hughes G. R., Ingelmo M., Ordinas A. Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis Rheum. 1998 Aug;41(8):1420–1427. doi: 10.1002/1529-0131(199808)41:8<1420::AID-ART11>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  36. Ross G. S., Bell J. Myocardial infarction associated with inappropriate use of topical cocaine as treatment for epistaxis. Am J Emerg Med. 1992 May;10(3):219–222. doi: 10.1016/0735-6757(92)90213-H. [DOI] [PubMed] [Google Scholar]
  37. Simpson H. C., Mann J. I., Meade T. W., Chakrabarti R., Stirling Y., Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet. 1983 Apr 9;1(8328):786–790. doi: 10.1016/s0140-6736(83)91849-4. [DOI] [PubMed] [Google Scholar]
  38. Simpson R. W., Edwards W. D. Pathogenesis of cocaine-induced ischemic heart disease. Autopsy findings in a 21-year-old man. Arch Pathol Lab Med. 1986 Jun;110(6):479–484. [PubMed] [Google Scholar]
  39. Takeda Y., Chen A. Y. Fibrinogen metabolism and distribution in patients with the nephrotic syndrome. J Lab Clin Med. 1967 Oct;70(4):678–685. [PubMed] [Google Scholar]
  40. Takeuchi S., Obayashi T., Toyama J. Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA. Heart. 1998 Jan;79(1):96–98. doi: 10.1136/hrt.79.1.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Taylor A. J., Byers J. P., Cheitlin M. D., Virmani R. Anomalous right or left coronary artery from the contralateral coronary sinus: "high-risk" abnormalities in the initial coronary artery course and heterogeneous clinical outcomes. Am Heart J. 1997 Apr;133(4):428–435. doi: 10.1016/s0002-8703(97)70184-4. [DOI] [PubMed] [Google Scholar]
  42. Vaarala O. Antibodies to oxidised LDL. Lupus. 2000;9(3):202–205. doi: 10.1191/096120300678828280. [DOI] [PubMed] [Google Scholar]
  43. Vaarala O. Antiphospholipid antibodies and atherosclerosis. Lupus. 1996 Oct;5(5):442–447. doi: 10.1177/096120339600500522. [DOI] [PubMed] [Google Scholar]
  44. Vaarala O., Puurunen M., Mänttäri M., Manninen V., Aho K., Palosuo T. Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemost. 1996 Mar;75(3):456–459. [PubMed] [Google Scholar]
  45. Vale P. R., Baron D. W. Coronary artery stenting for spontaneous coronary artery dissection: a case report and review of the literature. Cathet Cardiovasc Diagn. 1998 Nov;45(3):280–286. doi: 10.1002/(sici)1097-0304(199811)45:3<280::aid-ccd14>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  46. Valtonen V., Kuikka A., Syrjänen J. Thrombo-embolic complications in bacteraemic infections. Eur Heart J. 1993 Dec;14 (Suppl K):20–23. [PubMed] [Google Scholar]
  47. Vuorio A. F., Kontula K., Turtola H., Sajantila A. Post mortem molecularly defined familial hypercholesterolemia and sudden cardiac death of young men. Forensic Sci Int. 1999 Dec 6;106(2):87–92. doi: 10.1016/s0379-0738(99)00149-8. [DOI] [PubMed] [Google Scholar]
  48. Williams M. J., Restieaux N. J., Low C. J. Myocardial infarction in young people with normal coronary arteries. Heart. 1998 Feb;79(2):191–194. doi: 10.1136/hrt.79.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES